Skip to main content
PMC home page
Archives of Disease in Childhood logoLink to Archives of Disease in Childhood
. 2000 Apr;82(4):286–291. doi: 10.1136/adc.82.4.286

Active surveillance of hepatitis C infection in the UK and Ireland

D Gibb 1, P Neave 1, P Tookey 1, M Ramsay 1, H Harris 1, K Balogun 1, D Goldberg 1, G Mieli-Vergani 1, D Kelly 1
PMCID: PMC1718291  PMID: 10735833

Abstract

AIM—To investigate the prevalence, distribution, and clinical details of paediatric hepatitis C virus (HCV) infection in the UK and Ireland.
METHODS—Active monthly surveillance questionnaire study coordinated through the British Paediatric Surveillance Unit, to all consultant paediatricians in 1997 and 1998.
RESULTS—A total of 182 HCV infected children were reported from 54 centres and by paediatricians from eight different specialties. In 40 children HCV was acquired through mother to child transmission (MTC children); 142 were infected by contaminated blood products (n = 134), organ transplantation (n = 2), needles (n = 4), or unknown risk factor (n = 2). Intravenous drug use was the risk factor for 35 mothers of MTC children. Twelve children were coinfected with HIV and four with HBV. Recent serum aspartate aminotransferase or alanine aminotransferase values were at least twofold greater than the upper limit of normal in 24 of 152 children; this occurred in five of 11 HIV coinfected children. Liver histology, available in 53 children, showed normal (7%), mild (74%), moderate (17%), or severe (2%) hepatitis. Twenty eight children had received therapy with interferon alfa.
CONCLUSION—Most current paediatric HCV infection in UK and Ireland has been acquired from contaminated blood products, and most children are asymptomatic. There is a need for multicentre trials to inform clinical practice and development of good practice guidelines in this area. Long term follow up of this cohort of HCV infected children is planned to help determine the natural history over the long term of HCV acquired during infancy and childhood.



Full Text

The Full Text of this article is available as a PDF (135.8 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bortolotti F., Giacchino R., Vajro P., Barbera C., Crivellaro C., Alberti A., Nebbia G., Zancan L., De Moliner L., Bertolini A. Recombinant interferon-alfa therapy in children with chronic hepatitis C. Hepatology. 1995 Dec;22(6):1623–1627. [PubMed] [Google Scholar]
  2. Bortolotti F., Resti M., Giacchino R., Azzari C., Gussetti N., Crivellaro C., Barbera C., Mannelli F., Zancan L., Bertolini A. Hepatitis C virus infection and related liver disease in children of mothers with antibodies to the virus. J Pediatr. 1997 Jun;130(6):990–993. doi: 10.1016/s0022-3476(97)70289-0. [DOI] [PubMed] [Google Scholar]
  3. Davis G. L., Esteban-Mur R., Rustgi V., Hoefs J., Gordon S. C., Trepo C., Shiffman M. L., Zeuzem S., Craxi A., Ling M. H. Interferon alfa-2b alone or in combination with ribavirin for the treatment of relapse of chronic hepatitis C. International Hepatitis Interventional Therapy Group. N Engl J Med. 1998 Nov 19;339(21):1493–1499. doi: 10.1056/NEJM199811193392102. [DOI] [PubMed] [Google Scholar]
  4. García-Monzón C., Jara P., Fernández-Bermejo M., Hierro L., Frauca E., Camarena C., Díaz C., De la Vega A., Larrauri J., García-Iglesias C. Chronic hepatitis C in children: a clinical and immunohistochemical comparative study with adult patients. Hepatology. 1998 Dec;28(6):1696–1701. doi: 10.1002/hep.510280633. [DOI] [PubMed] [Google Scholar]
  5. Granovsky M. O., Minkoff H. L., Tess B. H., Waters D., Hatzakis A., Devoid D. E., Landesman S. H., Rubinstein A., Di Bisceglie A. M., Goedert J. J. Hepatitis C virus infection in the mothers and infants cohort study. Pediatrics. 1998 Aug;102(2 Pt 1):355–359. doi: 10.1542/peds.102.2.355. [DOI] [PubMed] [Google Scholar]
  6. Harris K. A., Gilham C., Mortimer P. P., Teo C. G. The most prevalent hepatitis C virus genotypes in England and Wales are 3a and 1a. J Med Virol. 1999 Jun;58(2):127–131. doi: 10.1002/(sici)1096-9071(199906)58:2<127::aid-jmv5>3.0.co;2-k. [DOI] [PubMed] [Google Scholar]
  7. Honda M., Kaneko S., Unoura M., Kobayashi K., Murakami S. Risk of hepatitis C virus infections through household contact with chronic carriers: analysis of nucleotide sequences. Hepatology. 1993 Jun;17(6):971–976. [PubMed] [Google Scholar]
  8. Iorio R., Pensati P., Porzio S., Fariello I., Guida S., Vegnente A. Lymphoblastoid interferon alfa treatment in chronic hepatitis C. Arch Dis Child. 1996 Feb;74(2):152–156. doi: 10.1136/adc.74.2.152. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Liang T. J. Combination therapy for hepatitis C infection. N Engl J Med. 1998 Nov 19;339(21):1549–1550. doi: 10.1056/NEJM199811193392112. [DOI] [PubMed] [Google Scholar]
  10. Matsuoka S., Tatara K., Hayabuchi Y., Taguchi Y., Mori K., Honda H., Itou S., Yuasa Y., Kuroda Y. Serologic, virologic, and histologic characteristics of chronic phase hepatitis C virus disease in children infected by transfusion. Pediatrics. 1994 Dec;94(6 Pt 1):919–922. [PubMed] [Google Scholar]
  11. McHutchison J. G., Gordon S. C., Schiff E. R., Shiffman M. L., Lee W. M., Rustgi V. K., Goodman Z. D., Ling M. H., Cort S., Albrecht J. K. Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. Hepatitis Interventional Therapy Group. N Engl J Med. 1998 Nov 19;339(21):1485–1492. doi: 10.1056/NEJM199811193392101. [DOI] [PubMed] [Google Scholar]
  12. Nicoll A., McGarrigle C., Brady A. R., Ades A. E., Tookey P., Duong T., Mortimer J., Cliffe S., Goldberg D., Tappin D. Epidemiology and detection of HIV-1 among pregnant women in the United Kingdom: results from national surveillance 1988-96. BMJ. 1998 Jan 24;316(7127):253–258. doi: 10.1136/bmj.316.7127.253. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Ramsay M. E., Balogun M. A., Collins M., Balraj V. Laboratory surveillance of hepatitis C virus infection in England and Wales: 1992 to 1996. Commun Dis Public Health. 1998 Jun;1(2):89–94. [PubMed] [Google Scholar]
  14. Resti M., Azzari C., Mannelli F., Moriondo M., Novembre E., de Martino M., Vierucci A. Mother to child transmission of hepatitis C virus: prospective study of risk factors and timing of infection in children born to women seronegative for HIV-1. Tuscany Study Group on Hepatitis C Virus Infection. BMJ. 1998 Aug 15;317(7156):437–441. doi: 10.1136/bmj.317.7156.437. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Seeff L. B., Buskell-Bales Z., Wright E. C., Durako S. J., Alter H. J., Iber F. L., Hollinger F. B., Gitnick G., Knodell R. G., Perrillo R. P. Long-term mortality after transfusion-associated non-A, non-B hepatitis. The National Heart, Lung, and Blood Institute Study Group. N Engl J Med. 1992 Dec 31;327(27):1906–1911. doi: 10.1056/NEJM199212313272703. [DOI] [PubMed] [Google Scholar]
  16. Spencer J. D., Latt N., Beeby P. J., Collins E., Saunders J. B., McCaughan G. W., Cossart Y. E. Transmission of hepatitis C virus to infants of human immunodeficiency virus-negative intravenous drug-using mothers: rate of infection and assessment of risk factors for transmission. J Viral Hepat. 1997;4(6):395–409. doi: 10.1046/j.1365-2893.1997.00073.x. [DOI] [PubMed] [Google Scholar]
  17. Thomas D. L., Villano S. A., Riester K. A., Hershow R., Mofenson L. M., Landesman S. H., Hollinger F. B., Davenny K., Riley L., Diaz C. Perinatal transmission of hepatitis C virus from human immunodeficiency virus type 1-infected mothers. Women and Infants Transmission Study. J Infect Dis. 1998 Jun;177(6):1480–1488. doi: 10.1086/515315. [DOI] [PubMed] [Google Scholar]
  18. Thomas S. L., Newell M. L., Peckham C. S., Ades A. E., Hall A. J. A review of hepatitis C virus (HCV) vertical transmission: risks of transmission to infants born to mothers with and without HCV viraemia or human immunodeficiency virus infection. Int J Epidemiol. 1998 Feb;27(1):108–117. doi: 10.1093/ije/27.1.108. [DOI] [PubMed] [Google Scholar]
  19. Thomas S. L., Newell M. L., Peckham C. S., Ades A. E., Hall A. J. Use of polymerase chain reaction and antibody tests in the diagnosis of vertically transmitted hepatitis C virus infection. Eur J Clin Microbiol Infect Dis. 1997 Oct;16(10):711–719. doi: 10.1007/BF01709250. [DOI] [PubMed] [Google Scholar]
  20. van der Poel C. L., Cuypers H. T., Reesink H. W. Hepatitis C virus six years on. Lancet. 1994 Nov 26;344(8935):1475–1479. doi: 10.1016/s0140-6736(94)90293-3. [DOI] [PubMed] [Google Scholar]

Articles from Archives of Disease in Childhood are provided here courtesy of BMJ Publishing Group

RESOURCES